Site Number - 1630 — Washington D.C., District of Columbia

Site Number - 1630 is a clinical research site located in Washington D.C., District of Columbia, United States 20010.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

Site Number - 1630 has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Chronic Inflammatory Demyelinating Polyneuropathy.

Sponsors: Immunovant Sciences GmbH.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site Number - 1630?

Site Number - 1630 has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site Number - 1630 conducted?

Site Number - 1630 has 2 clinical trials on record, with 2 currently active. Their work covers Chronic Inflammatory Demyelinating Polyneuropathy.

Is Site Number - 1630 accredited by Crixeo Health?

Site Number - 1630 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site Number - 1630?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.